trending Market Intelligence /marketintelligence/en/news-insights/trending/l33u1-ockdxsl7cp7od88q2 content esgSubNav
In This List

Ziopharm Oncology nominates board member

Video

According to Market Intelligence, December 2022

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022


Ziopharm Oncology nominates board member

Ziopharm Oncology Inc. named Scott Braunstein for election to its board at the company's annual meeting of stockholders on Sept. 18.

Braunstein has been a partner at Aisling Capital Management LP since August 2015. He has also served as COO of Pacira Pharmaceuticals Inc.